298 related articles for article (PubMed ID: 26279424)
1. Tempol, a Superoxide Dismutase-Mimetic Drug, Ameliorates Progression of Renal Disease in CKD Mice.
Ding W; Wang B; Zhang M; Gu Y
Cell Physiol Biochem; 2015; 36(6):2170-82. PubMed ID: 26279424
[TBL] [Abstract][Full Text] [Related]
2. Assessing the effects of tempol on renal fibrosis, inflammation, and oxidative stress in a high-salt diet combined with 5/6 nephrectomy rat model: utilizing oxidized albumin as a biomarker.
Liu B; Hu Y; Tian D; Dong J; Li BF
BMC Nephrol; 2024 Feb; 25(1):64. PubMed ID: 38395806
[TBL] [Abstract][Full Text] [Related]
3. Effect of chronic antioxidant therapy with superoxide dismutase-mimetic drug, tempol, on progression of renal disease in rats with renal mass reduction.
Quiroz Y; Ferrebuz A; Vaziri ND; Rodriguez-Iturbe B
Nephron Exp Nephrol; 2009; 112(1):e31-42. PubMed ID: 19342872
[TBL] [Abstract][Full Text] [Related]
4. The superoxide dismutase mimetic tempol blunts diabetes-induced upregulation of NADPH oxidase and endoplasmic reticulum stress in a rat model of diabetic nephropathy.
De Blasio MJ; Ramalingam A; Cao AH; Prakoso D; Ye JM; Pickering R; Watson AMD; de Haan JB; Kaye DM; Ritchie RH
Eur J Pharmacol; 2017 Jul; 807():12-20. PubMed ID: 28438648
[TBL] [Abstract][Full Text] [Related]
5. Ophiocordyceps lanpingensis polysaccharides alleviate chronic kidney disease through MAPK/NF-κB pathway.
Zhou S; He Y; Zhang W; Xiong Y; Jiang L; Wang J; Cui X; Qu Y; Ge F
J Ethnopharmacol; 2021 Aug; 276():114189. PubMed ID: 33964361
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats.
Wang DT; Huang RH; Cheng X; Zhang ZH; Yang YJ; Lin X
Int Immunopharmacol; 2015 May; 26(1):4-12. PubMed ID: 25744602
[TBL] [Abstract][Full Text] [Related]
7. Tempol, a superoxide dismutase-mimetic drug, prevents chronic ischemic renal injury in two-kidney, one-clip hypertensive rats.
Nunes DV; Costa CA; De Bem GF; Cordeiro VS; Santos IB; Carvalho LC; Jordão AK; Cunha AC; Ferreira VF; Moura RS; Resende AC; Ognibene DT
Clin Exp Hypertens; 2018; 40(8):721-729. PubMed ID: 29359965
[TBL] [Abstract][Full Text] [Related]
8. Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice.
Kobayashi M; Sugiyama H; Wang DH; Toda N; Maeshima Y; Yamasaki Y; Masuoka N; Yamada M; Kira S; Makino H
Kidney Int; 2005 Sep; 68(3):1018-31. PubMed ID: 16105032
[TBL] [Abstract][Full Text] [Related]
9. Superoxide and hydrogen peroxide counterregulate myogenic contractions in renal afferent arterioles from a mouse model of chronic kidney disease.
Li L; Lai EY; Luo Z; Solis G; Griendling KK; Taylor WR; Jose PA; Wellstein A; Welch WJ; Wilcox CS
Kidney Int; 2017 Sep; 92(3):625-633. PubMed ID: 28396118
[TBL] [Abstract][Full Text] [Related]
10. Tangeretin ameliorates renal failure via regulating oxidative stress, NF-κB-TNF-α/iNOS signalling and improves memory and cognitive deficits in 5/6 nephrectomized rats.
Wu J; Zhao YM; Deng ZK
Inflammopharmacology; 2018 Feb; 26(1):119-132. PubMed ID: 28871498
[TBL] [Abstract][Full Text] [Related]
11. Effects of Single and Combined Losartan and Tempol Treatments on Oxidative Stress, Kidney Structure and Function in Spontaneously Hypertensive Rats with Early Course of Proteinuric Nephropathy.
Karanovic D; Grujic-Milanovic J; Miloradovic Z; Ivanov M; Jovovic D; Vajic UJ; Zivotic M; Markovic-Lipkovski J; Mihailovic-Stanojevic N
PLoS One; 2016; 11(8):e0161706. PubMed ID: 27560781
[TBL] [Abstract][Full Text] [Related]
12. Tempol attenuates renal fibrosis in mice with unilateral ureteral obstruction: the role of PI3K-Akt-FoxO3a signaling.
Yoon HE; Kim SJ; Kim SJ; Chung S; Shin SJ
J Korean Med Sci; 2014 Feb; 29(2):230-7. PubMed ID: 24550650
[TBL] [Abstract][Full Text] [Related]
13. Tempol Protects Against Acute Renal Injury by Regulating PI3K/Akt/mTOR and GSK3β Signaling Cascades and Afferent Arteriolar Activity.
Zhang G; Wang Q; Wang W; Yu M; Zhang S; Xu N; Zhou S; Cao X; Fu X; Ma Z; Liu R; Mao J; Lai EY
Kidney Blood Press Res; 2018; 43(3):904-913. PubMed ID: 29870982
[TBL] [Abstract][Full Text] [Related]
14. Diet-induced renal changes in Zucker rats are ameliorated by the superoxide dismutase mimetic TEMPOL.
Ebenezer PJ; Mariappan N; Elks CM; Haque M; Francis J
Obesity (Silver Spring); 2009 Nov; 17(11):1994-2002. PubMed ID: 19424163
[TBL] [Abstract][Full Text] [Related]
15. Compound α-keto acid tablet supplementation alleviates chronic kidney disease progression via inhibition of the NF-kB and MAPK pathways.
Wang M; Xu H; Chong Lee Shin OL; Li L; Gao H; Zhao Z; Zhu F; Zhu H; Liang W; Qian K; Zhang C; Zeng R; Zhou H; Yao Y
J Transl Med; 2019 Apr; 17(1):122. PubMed ID: 30975176
[TBL] [Abstract][Full Text] [Related]
16. Indoxyl sulfate potentiates endothelial dysfunction via reciprocal role for reactive oxygen species and RhoA/ROCK signaling in 5/6 nephrectomized rats.
Chu S; Mao X; Guo H; Wang L; Li Z; Zhang Y; Wang Y; Wang H; Zhang X; Peng W
Free Radic Res; 2017 Mar; 51(3):237-252. PubMed ID: 28277985
[TBL] [Abstract][Full Text] [Related]
17. Superoxide dismutase mimetic drug tempol aggravates anti-GBM antibody-induced glomerulonephritis in mice.
Lu H; Zhen J; Wu T; Peng A; Ye T; Wang T; Yu X; Vaziri ND; Mohan C; Zhou XJ
Am J Physiol Renal Physiol; 2010 Aug; 299(2):F445-52. PubMed ID: 20504883
[TBL] [Abstract][Full Text] [Related]
18. Targeting multiple pathways reduces renal and cardiac fibrosis in rats with subtotal nephrectomy followed by coronary ligation.
Oosterhuis NR; Bongartz LG; Verhaar MC; Cheng C; Xu YJ; van Koppen A; Cramer MJ; Goldschmeding R; Gaillard CA; Doevendans PA; Braam B; Joles JA
Acta Physiol (Oxf); 2017 Jul; 220(3):382-393. PubMed ID: 28168814
[TBL] [Abstract][Full Text] [Related]
19. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
20. Triiodothyronine attenuates the progression of renal injury in a rat model of chronic kidney disease.
El Agaty SM
Can J Physiol Pharmacol; 2018 Jun; 96(6):603-610. PubMed ID: 29406830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
